New authorization IMP
June 17, 2021Fulton receives from AIFA a new authorization for the Investigational Medicinal Product (IMP) production of the suppositories pharmaceutical form.
Fulton receives from AIFA a new authorization for the Investigational Medicinal Product (IMP) production of the suppositories pharmaceutical form.